On September 18, Almazov Centre hosted the scientific and practical conference with international participation Professor Zaritskey Discussion Club, themed “Chronic myeloid leukemia – standards and innovations in patient management”.
The conference focused on the problems of diagnosis and therapy of patients with chronic myeloid leukemia. The invited experts discussed challenges in the diagnosis and treatment of patients at different stages of chronic myeloid leukemia.
The conference brought together hematologists, morphologists, specialists in molecular genetic testing, clinical residents and researchers.
The event was held in hybrid format. It was held as part of the programme of the WCRC for Personalized Medicine and supported by the Russian Ministry of Science and Higher Education.
The conference covered the following topics:
• New technologies in the assessment of CML treatment outcomes
• Chronic myeloid leukemia in real clinical practice
• Optimization of treatment approaches for chronic phase CML
• Current practice and prospects for CML management
Among the honorary chairs of the Scientific and Organizing Committee were Rüdiger Helmann, founder and chairman of the European LeukemiaNet (ELN), Evgeny Shlyakhto, Director General of Almazov Centre, and Alexandra Konradi, Deputy Director General for Research.